To uncover OPA1’s pivotal role in mediating PFKFB3’s protection against DCM, we utilized a cardiomyocyte-specific viral shRNA targeting OPA1, driven by the cTnT promoter (Fig. 5A). This evidence concerns the gene TNNT2 and familial dilated cardiomyopathy.